< Back to all clusters
[HEALTH] · Brazil · 55 sources

started · updated

Brazil's Anvisa orders recall of Paramol batch and seizes counterfeit Mounjaro

The Brazilian health regulator Anvisa suspended sales and ordered the recall of the Paramol 750 mg tablet batch (lot 114053, 200‑tablet packs) after detecting mold contamination in the product manufactured by Belfar Ltda. Consumers were advised to stop using the drug and contact the company for refunds or replacement.

In a separate action, Anvisa also issued a resolution to seize counterfeit units of the diabetes/obesity medication Mounjaro (tirzepatide) identified by Eli Lilly do Brasil Ltda. The affected lot is D881474, but the units bear an unauthorized serial number 302199651396, prompting a nationwide recall and a warning to purchase medicines only from authorized pharmacies.

Both measures aim to protect public health by removing potentially unsafe or falsified medicines from the market and to inform patients to verify packaging and lot numbers before use.

Entities

Agência Nacional de Vigilância Sanitária · Agência Nacional de Vigilância Sanitária (Anvisa) · Anaber – Cosméticos Indústria e Comércio Ltda · Anaber – Cosméticos Indústria e Comércio Ltda. · Anvisa · Anvisa (Agência Nacional de Vigilância Sanitária) · Belfar Ltda. · Brazil · Cecco · Cia Bel de Alimentos (Festval) · Creme Relaxante Miss Hidrat · Eli Lilly do Brasil

Claims

What the coverage asserts, and how many sources carry each claim.

Sources

about 2 months ago
about 2 months ago
about 2 months ago
about 2 months ago